Insumate
Commercial- Indications
- Glucose metabolism
Company intelligence / Profile preview
Greenyn Biotechnology
Taichung City, Taiwangreenynbio.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Greenyn Biotechnology has developed several proprietary dietary supplement ingredients with clinical validation. Their Insumate® bitter melon extract contains a patented peptide shown to modulate blood glucose in human studies. Their Antromax® Antrodia cinnamomea mycelium product has demonstrated safety and efficacy for liver health and hangover relief in human trials, including use on chronic hepatitis patients with no observed side effects. The company holds multiple international patents and certifications.
- Therapeutic areas
- OtherEndocrinologyInfectious Diseases
- Modalities
- Botanical extract (e.g., Antrodia cinnamomea mycelium)Peptides (e.g., mcIRBP-19 in Insumate® bitter melon extract)Fermented product (phyto fermented drink)Small molecule (triterpenoids from mycelium)Functional food ingredient
- Industry
- Food & Nutrition
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with domestic academic and medical institutionsexclusive distributor relationships for foreign dietary supplement raw materials
Beyond the preview
Go deeper on Greenyn Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Greenyn Biotechnology.